Cargando…
Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice
Obesity and type 2 diabetes are the most common metabolic diseases globally. They are associated with inflammation, oxidative stress, autophagy, and insulin resistance. Sitagliptin, a dipeptidyl-peptidase 4 inhibitor, has been reported to show multiple biological activities beyond the antidiabetic p...
Autores principales: | Zheng, Wenbin, Zhou, Jing, Song, Shasha, Kong, Wen, Xia, Wenfang, Chen, Lulu, Zeng, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079465/ https://www.ncbi.nlm.nih.gov/pubmed/30123267 http://dx.doi.org/10.1155/2018/8309723 |
Ejemplares similares
-
Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice
por: Sujishi, Tetsuya, et al.
Publicado: (2015) -
Abdominal Irradiation Ameliorates Obesity in ob/ob Mice
por: Okada, Sumiyo, et al.
Publicado: (2007) -
The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice
por: Martagón, Alexandro J., et al.
Publicado: (2015) -
Peripheral nervous system insulin resistance in ob/ob mice
por: Grote, Caleb W, et al.
Publicado: (2013) -
Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice
por: Wang, Xianfeng, et al.
Publicado: (2016)